• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

视网膜母细胞瘤伴完全渗出性视网膜脱离:治疗与结局。

RETINOBLASTOMA ASSOCIATED WITH TOTAL EXUDATIVE RETINAL DETACHMENT: Treatment and Outcomes.

机构信息

Operation Eyesight Universal Institute for Eye Cancer, L V Prasad Eye Institute, Hyderabad, India.

出版信息

Retina. 2023 May 1;43(5):808-814. doi: 10.1097/IAE.0000000000003734.

DOI:10.1097/IAE.0000000000003734
PMID:36728575
Abstract

PURPOSE

To study the clinical presentation, treatment, and outcomes of eyes presenting with retinoblastoma and total retinal detachment.

METHODS

A retrospective study of 50 eyes in 43 patients.

RESULTS

The mean age at presentation was 15 months (median, 9 months). Retinoblastoma-associated total retinal detachment was unilateral (n = 36; 84%) or bilateral (n = 7; 16%). The mean tumor basal diameter was 17 mm (median, 18 mm), and the mean tumor thickness was 13 mm (median, 12 mm). Associated features included subretinal seeds (n = 26; 52%), vitreous seeds (n = 13; 26%), and subretinal exudation (n = 4; 8%). Based on eighth edition of American Joint Committee on Cancer classification, the tumors were classified as cT2a (n = 19; 38%), cT2b (n = 28; 56%), or cT3c (n = 3; 6%). Primary treatment included intravenous (n = 48; 96%) or intraarterial chemotherapy (n = 2; 4%). Over a mean follow-up period of 30 months (median, 29 months; range, 7-62 months), retinal detachment resolved in 41 eyes (82%), tumor recurrence was noted in 39 eyes (78%), globe salvage was achieved in 35 eyes (70%), and one patient (2%) died due to metastasis.

CONCLUSION

Relatively high tumor recurrence rate is noted in retinoblastoma presenting with total retinal detachment. With appropriate treatment, 70% of the globes can be salvaged.

摘要

目的

研究伴有视网膜母细胞瘤和全视网膜脱离的眼的临床表现、治疗和结局。

方法

对 43 例患者的 50 只眼进行回顾性研究。

结果

就诊时的平均年龄为 15 个月(中位数为 9 个月)。视网膜母细胞瘤相关的全视网膜脱离为单侧(n = 36;84%)或双侧(n = 7;16%)。平均肿瘤基底直径为 17mm(中位数为 18mm),平均肿瘤厚度为 13mm(中位数为 12mm)。相关特征包括视网膜下种子(n = 26;52%)、玻璃体种子(n = 13;26%)和视网膜下渗出(n = 4;8%)。根据第八版美国癌症联合委员会分类,肿瘤分为 cT2a(n = 19;38%)、cT2b(n = 28;56%)或 cT3c(n = 3;6%)。主要治疗方法包括静脉内(n = 48;96%)或动脉内化疗(n = 2;4%)。在平均 30 个月(中位数,29 个月;范围,7-62 个月)的随访期间,41 只眼(82%)视网膜脱离得到缓解,39 只眼(78%)出现肿瘤复发,35 只眼(70%)眼球得以保存,1 例患者(2%)因转移而死亡。

结论

伴有全视网膜脱离的视网膜母细胞瘤复发率相对较高。通过适当的治疗,70%的眼球可以保存。

相似文献

1
RETINOBLASTOMA ASSOCIATED WITH TOTAL EXUDATIVE RETINAL DETACHMENT: Treatment and Outcomes.视网膜母细胞瘤伴完全渗出性视网膜脱离:治疗与结局。
Retina. 2023 May 1;43(5):808-814. doi: 10.1097/IAE.0000000000003734.
2
Effect of intraarterial chemotherapy on retinoblastoma-induced retinal detachment.眼动脉化疗对视网膜母细胞瘤相关性视网膜脱离的影响。
Retina. 2012 Apr;32(4):799-804. doi: 10.1097/IAE.0b013e31823d8e1e.
3
RHEGMATOGENOUS RETINAL DETACHMENT AFTER INTRAARTERIAL CHEMOTHERAPY FOR RETINOBLASTOMA: The 2016 Founders Award Lecture.视网膜母细胞瘤动脉内化疗后发生的孔源性视网膜脱离:2016年创始人奖讲座
Retina. 2017 Aug;37(8):1441-1450. doi: 10.1097/IAE.0000000000001382.
4
Rescue intra-arterial chemotherapy following retinoblastoma recurrence after initial intra-arterial chemotherapy.初始动脉内化疗后视网膜母细胞瘤复发后的挽救性动脉内化疗。
J Fr Ophtalmol. 2015 Jun;38(6):542-9. doi: 10.1016/j.jfo.2015.03.004. Epub 2015 May 14.
5
The effect of chemoreduction on retinoblastoma-induced retinal detachment.
J Pediatr Ophthalmol Strabismus. 1997 May-Jun;34(3):165-9. doi: 10.3928/0191-3913-19970501-07.
6
Factors predictive of recurrence of retinal tumors, vitreous seeds, and subretinal seeds following chemoreduction for retinoblastoma.视网膜母细胞瘤化疗减积术后视网膜肿瘤、玻璃体种植和视网膜下种植复发的预测因素。
Arch Ophthalmol. 2002 Apr;120(4):460-4.
7
Secondary and tertiary intra-arterial chemotherapy for massive persistent or recurrent subretinal retinoblastoma seeds following previous chemotherapy exposure: long-term tumor control and globe salvage in 30 eyes.既往接受化疗后,对大量持续性或复发性视网膜母细胞瘤视网膜下种植灶进行二期和三期动脉内化疗:30只眼的长期肿瘤控制和眼球挽救情况
J AAPOS. 2016 Aug;20(4):337-42. doi: 10.1016/j.jaapos.2016.05.009. Epub 2016 Jun 18.
8
Management and outcome of retinoblastoma with vitreous seeds.玻璃体内播散性视网膜母细胞瘤的处理和结局。
Ophthalmology. 2014 Feb;121(2):517-24. doi: 10.1016/j.ophtha.2013.09.011. Epub 2013 Oct 25.
9
Intra-arterial chemotherapy for retinoblastoma in 70 eyes: outcomes based on the international classification of retinoblastoma.70 只眼的眼内动脉化疗治疗视网膜母细胞瘤:基于视网膜母细胞瘤国际分类的结果。
Ophthalmology. 2014 Jul;121(7):1453-60. doi: 10.1016/j.ophtha.2014.01.026. Epub 2014 Mar 21.
10
Management of Recurrence in Retinoblastoma Based on the Source of Tumor Cells.基于肿瘤细胞来源的视网膜母细胞瘤复发管理
Middle East Afr J Ophthalmol. 2024 Jan 22;30(1):24-30. doi: 10.4103/meajo.meajo_112_23. eCollection 2023 Jan-Mar.

引用本文的文献

1
Electroretinographic changes in the inner and outer retinal layers before and after intravenous chemotherapy for retinoblastoma.静脉化疗治疗视网膜母细胞瘤前后内层和外层视网膜的视网膜电图变化。
Indian J Ophthalmol. 2024 Aug 1;72(8):1168-1174. doi: 10.4103/IJO.IJO_2722_23. Epub 2024 Jul 29.